{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:01:08Z","timestamp":1790420468768,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108328","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:23Z","timestamp":1790264723000},"page":"108328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML\/MDS patients"],"prefix":"10.1016","volume":"171","author":[{"given":"Witold","family":"Prejzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Sadowska-Klasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Lakner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-1136","authenticated-orcid":false,"given":"Anastazja","family":"Szlauer-Stefa\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u0141ojko-Dankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Majcherek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-5041","authenticated-orcid":false,"given":"Ewa","family":"Karakulska-Prystupiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Mensah-Glanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-0182","authenticated-orcid":false,"given":"Anna","family":"Czy\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Junghanss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-025-01099-7","article-title":"The global epidemiology of acute myeloid leukaemia","volume":"23","author":"El Chaer","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib2","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2022.280798","article-title":"New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia","volume":"108","author":"Mohty","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108328_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-026-02919-9","article-title":"The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy","author":"Greco","year":"2026","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.leukres.2026.108328_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtct.2025.07.004","article-title":"Allogeneic hematopoietic cell donor selection: contemporary guidelines from the NMDP\/CIBMTR","volume":"31","author":"Jimenez Jimenez","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41409-025-02751-7","article-title":"Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: a study from the EBMT acute leukemia working party","volume":"61","author":"Villalba","year":"2026","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.leukres.2026.108328_bib6","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2026.108328_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2007.01.073","article-title":"Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia","volume":"13","author":"Moore","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"17","key":"10.1016\/j.leukres.2026.108328_bib8","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2026.108328_bib9","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/ajh.70069","volume":"100","author":"Ru","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"13","key":"10.1016\/j.leukres.2026.108328_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-08-453860","article-title":"Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?","volume":"121","author":"Alousi","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib11","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2026.108328_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26870","article-title":"Younger haploidentical donor versus older matched unrelated donor for patients with AML\/MDS","volume":"98","author":"Marcoux","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108328_bib13","article-title":"Impact of donor age in haploidentical-post-transplantation cyclophosphamide versus matched unrelated donor post-transplantation cyclophosphamide hematopoietic stem cell transplantation in patients with acute myeloid leukemia","volume":"29","author":"Mehta","year":"2023","journal-title":"Transplant. Cell. Ther."},{"issue":"ement 1","key":"10.1016\/j.leukres.2026.108328_bib14","article-title":"Unrelated Donors below 35 years of age should be preferred over HLA-matched sibling donors older than 50 years for patients with myeloid malignancies","volume":"142","author":"Schetelig","year":"2023","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2026.108328_bib15","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2026.108328_bib16","article-title":"Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients","volume":"55","author":"Spyridonidis","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.leukres.2026.108328_bib17","series-title":"The EBMT Handbook","first-page":"307","article-title":"Graft failure","author":"Valc\u00e1rcel","year":"2019"},{"issue":"3","key":"10.1016\/j.leukres.2026.108328_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"36","key":"10.1016\/j.leukres.2026.108328_bib19","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2017.75.8177","article-title":"Prospective, randomized, double-blind, phase III clinical trial of anti-T-lymphocyte globulin to assess impact on chronic graft-versus-host disease-free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation","volume":"35","author":"Soiffer","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib20","article-title":"Comparison of allogeneic hematopoietic cell transplantation outcomes from younger matched unrelated donor versus older sibling donor for older adults with AML","volume":"29","author":"Abid","year":"2023","journal-title":"Transplant. Cell. Ther."},{"issue":"8","key":"10.1016\/j.leukres.2026.108328_bib21","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/curroncol29080470","article-title":"Donor age and non-relapse mortality: study of their association after HLA-matched allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"29","author":"Kadri","year":"2022","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib22","volume":"30","author":"Konuma","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"3","key":"10.1016\/j.leukres.2026.108328_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Kr\u00f6ger","year":"2013","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.leukres.2026.108328_bib24","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2023023697","article-title":"Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT","volume":"143","author":"Sanz","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2026.108328_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.leukres.2026.108328_bib26","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation in patients aged 70 years and older: a systematic review and meta-analysis","volume":"31","author":"Shahzad","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"5","key":"10.1016\/j.leukres.2026.108328_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-026-06736-4","article-title":"Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry","volume":"105","author":"Welsch","year":"2026","journal-title":"Ann. Hematol."},{"issue":"21","key":"10.1016\/j.leukres.2026.108328_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.60.1203","article-title":"High graft CD8 cell dose predicts improved survival and enables better donor selection in allogeneic stem-cell transplantation with reduced-intensity conditioning","volume":"33","author":"Reshef","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"16_","key":"10.1016\/j.leukres.2026.108328_bib29","article-title":"Outcomes of older matched sibling donors compared to younger matched unrelated donors in allogeneic hematopoietic cell transplantation for AML in first complete remission","volume":"43","author":"Wang","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108328_bib30","article-title":"Comparison of older related versus younger unrelated donors for older recipients of allogeneic hematopoietic cell transplantation with acute myeloid leukemia or myelodysplastic syndrome: a large single-center analysis","volume":"30","author":"Kim","year":"2024","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.leukres.2026.108328_bib31","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.92549","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia: a systematic review","author":"Mohamed Ahmed","year":"2025","journal-title":"Cureus"},{"issue":"ement 1","key":"10.1016\/j.leukres.2026.108328_bib32","article-title":"Comparing older matched related to younger matched unrelated donors in acute myeloid leukemia in remission using post-transplant cyclophosphamide","volume":"142","author":"Piemontese","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2026.108328_bib33","article-title":"Choosing between older matched sibling donor and younger matched unrelated donor in allogeneic hematopoietic cell transplantation: comparison of clinical outcomes in acute myeloid leukemia and myelodysplastic syndrome","volume":"29","author":"Pereira","year":"2023","journal-title":"Transplant. Cell. Ther."},{"issue":"2","key":"10.1016\/j.leukres.2026.108328_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.2016.148510","article-title":"Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Baron","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.leukres.2026.108328_bib35","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.18632\/oncotarget.14719","article-title":"Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.leukres.2026.108328_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kroger","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2026.108328_bib37","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.937356","article-title":"Reduced risk of chronic graft-versus-host disease (cGVHD) by rabbit anti-thymocyte globulin (ATG) in patients undergoing matched sibling donor transplantation in hematological malignancies","volume":"27","author":"Fang","year":"2022","journal-title":"Ann. Transplant."},{"issue":"12","key":"10.1016\/j.leukres.2026.108328_bib38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41409-025-02692-1","article-title":"Improved GVHD-free relapse-free survival when rATG\/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the transplant complications working party","volume":"60","author":"Piekarska","year":"2025","journal-title":"Bone Marrow Transplant."},{"issue":"29","key":"10.1016\/j.leukres.2026.108328_bib39","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1200\/JCO.20.00150","article-title":"Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study","volume":"38","author":"Chang","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108328_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00277-019-03884-8","article-title":"Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies","volume":"99","author":"Dou","year":"2020","journal-title":"Ann. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108328_bib41","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1007\/s00277-025-06608-3","article-title":"Cytogenetic risk-associated outcomes of antithymocyte globulin use in HLA-matched sibling transplantation for acute myeloid leukemia","volume":"104","author":"Kim","year":"2025","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108328_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2013.01.010","article-title":"Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant","volume":"51","author":"Jaime-P\u00e9rez","year":"2013","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:42:41Z","timestamp":1790419361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0145212626001724"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108328","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML\/MDS patients","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108328"}}